课题基金 / 基金详情

SYNTHESIS OF TUBULIN BINDING ANTITUMOR AGENTS

SYNTHESIS OF TUBULIN BINDING ANTITUMOR AGENTS
微管蛋白结合抗肿瘤剂的合成
批准号:
2012376
负责人:
STEVEN D. BURKE
金额:
$17.58万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2000-06-30

项目摘要

项目成果

STEVEN D. BURKE的其他基金

相关文献

中文摘要
翻译
描述:提出的研究结合了方法论和总量
英文摘要
DESCRIPTION: The proposed research combines methodology and total synthesis. The targets chosen for total synthesis are halichondrin and rhizoxin. Both natural products are relatively scarce and demonstrate potent antimitotic activity by binding to the vinca domain on tubulin. In vivo activity against vinblastine and vincristine resistant cell lines has led to the selection of rhizoxin for Phase II clinical evaluation, and halichondrin B is currently in preclinical development. As a key strategy in both syntheses, two-directional chain synthesis is being applied. Three new methods for the synthesis of polysubstituted hydropyrans are also proposed. Planned variations of the Claisen rearrangement include a tandem glycolate ester enolate Claisen/ring-closing metathesis sequence, a desymmetrization of C2-symmetric substrates via a dioxanone rearrangement, and asymmetric catalysis of the dioxanone Claisen rearrangement by cationic metal complexes. Based on the second method, a short synthesis of KDO, a membrane component of Gram-negative bacteria, is proposed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expeditious Synthesis of Complexity and Diversity
  • 批准号:
    6858826
  • 项目类别:
  • 资助金额:
    $22.94万
  • 财政年份:
    2004
  • 负责人:
    STEVEN D. BURKE
  • 依托单位:
Expeditious Synthesis of Complexity and Diversity
  • 批准号:
    7014518
  • 项目类别:
  • 资助金额:
    $22.39万
  • 财政年份:
    2004
  • 负责人:
    STEVEN D. BURKE
  • 依托单位:
Macrocyclic Enyne Methathesis and Its Applications
  • 批准号:
    7153483
  • 项目类别:
  • 资助金额:
    $21.87万
  • 财政年份:
    2004
  • 负责人:
    STEVEN D. BURKE
  • 依托单位:
Expeditious Synthesis of Complexity and Diversity
  • 批准号:
    6731271
  • 项目类别:
  • 资助金额:
    $22.05万
  • 财政年份:
    2004
  • 负责人:
    STEVEN D. BURKE
  • 依托单位: